Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History AYTU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics AYTU

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Aytu BioScience Inc

AYTU
Current price
2.18 USD -0.11 USD (-4.80%)
Last closed 2.29 USD
ISIN US0547548745
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 20 557 124 USD
Yield for 12 month -22.70 %
1Y
3Y
5Y
10Y
15Y
AYTU
21.11.2021 - 28.11.2021

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above, and Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado. Address: Denver Corporate Center III, Denver, CO, United States, 80237

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.50 USD

P/E Ratio

Dividend Yield

Financials AYTU

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures AYTU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+81 002 000 USD

Last Year

+107 399 000 USD

Current Quarter

+18 452 000 USD

Last Quarter

+16 221 000 USD

Current Year

+54 586 000 USD

Last Year

+66 632 000 USD

Current Quarter

+12 806 000 USD

Last Quarter

+10 786 000 USD
EBITDA 6 000 000 USD
Operating Margin TTM 13.12 %
Price to Earnings
Return On Assets TTM -0.59 %
PEG Ratio
Return On Equity TTM -3.06 %
Wall Street Target Price 10.50 USD
Revenue TTM 81 659 000 USD
Book Value 5.66 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 31.60 %
Dividend Yield
Gross Profit TTM 52 891 000 USD
Earnings per share -1.49 USD
Diluted Eps TTM -1.49 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin 2.01 %

Stock Valuation AYTU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 3.69
Enterprise Value Revenue 0.30
Price Sales TTM 0.25
Enterprise Value EBITDA 2.30
Price Book MRQ 0.61

Technical Indicators AYTU

For 52 Weeks

0.95 USD 2.87 USD
50 Day MA 1.85 USD
Shares Short Prior Month 624 633
200 Day MA 1.67 USD
Short Ratio 0.17
Shares Short 492 409
Short Percent 8.81 %